Document is current
Any future updates will be listed below
-
Authors
Alsaloum, Matthew http://orcid.org/0000-0002-9832-0138
Higerd, Grant P. http://orcid.org/0000-0001-8288-576X
Effraim, Philip R.
Waxman, Stephen G. http://orcid.org/0000-0001-5718-7177
- License Information
-
More Information
Article History
Accepted: 10 September 2020
First Online: 27 October 2020
Competing interests
: S.G.W. has received research funding from Pfizer, has served as a consultant or adviser to Alnylam Pharmaceuticals, Amgen, Biogen, Chromocell, Exicure, GlaxoSmithKline, Eli Lilly Research, Sangamo Therapeutics, and Redpin Therapeutics, and serves on the Scientific Advisory Boards of SiteOne Therapeutics and OliPass. All other authors declare no competing interests.
